| (HKD) | Dec 2023 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -28.84M | -30.58% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 1312.HK returned +3.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +10.3% |
| 1 year | +3.2% |
| 5 years | -55.9% |
| 10 years | -95.2% |
| All-time high | $1.90 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 1312.HK would be worth today ›No. Kontafarma China Holdings Limited has not paid a dividend in the past 12 months.
Kontafarma China Holdings Limited is part of the Healthcare sector.
Kontafarma China Holdings Limited has a market cap of 167.66M HKD, based on the latest quote.
